Clinical Trial Update: Botulinum Toxin Type A in Diabetic Peripheral Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating botulinum toxin type A in diabetic neuropathies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathies

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Alexandria University | Conditions: Diabetic Neuropathies | Phase 4 | Status: COMPLETED